Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aditya Mohan

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Nature Communications|February 16, 2017
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
Journal of Hepatology|November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCCZeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Nature Cancer|November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor ImmunityWon Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Nature Communications|February 16, 2017
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
Journal of Hepatology|November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCCZeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Nature Cancer|November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor ImmunityWon Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.
Pageof 6